1. Home
  2. ENVB vs SMX Comparison

ENVB vs SMX Comparison

Compare ENVB & SMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • SMX
  • Stock Information
  • Founded
  • ENVB 1994
  • SMX N/A
  • Country
  • ENVB United States
  • SMX Ireland
  • Employees
  • ENVB N/A
  • SMX N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • SMX Industrial Machinery/Components
  • Sector
  • ENVB Health Care
  • SMX Technology
  • Exchange
  • ENVB Nasdaq
  • SMX Nasdaq
  • Market Cap
  • ENVB 3.0M
  • SMX 2.9M
  • IPO Year
  • ENVB N/A
  • SMX N/A
  • Fundamental
  • Price
  • ENVB $5.63
  • SMX $5.86
  • Analyst Decision
  • ENVB Strong Buy
  • SMX
  • Analyst Count
  • ENVB 1
  • SMX 0
  • Target Price
  • ENVB $120.00
  • SMX N/A
  • AVG Volume (30 Days)
  • ENVB 128.8K
  • SMX 674.3K
  • Earning Date
  • ENVB 11-14-2025
  • SMX 01-01-0001
  • Dividend Yield
  • ENVB N/A
  • SMX N/A
  • EPS Growth
  • ENVB N/A
  • SMX N/A
  • EPS
  • ENVB N/A
  • SMX N/A
  • Revenue
  • ENVB N/A
  • SMX N/A
  • Revenue This Year
  • ENVB N/A
  • SMX N/A
  • Revenue Next Year
  • ENVB N/A
  • SMX N/A
  • P/E Ratio
  • ENVB N/A
  • SMX N/A
  • Revenue Growth
  • ENVB N/A
  • SMX N/A
  • 52 Week Low
  • ENVB $4.88
  • SMX $5.13
  • 52 Week High
  • ENVB $96.30
  • SMX $66,187.38
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 59.55
  • SMX 66.57
  • Support Level
  • ENVB $4.88
  • SMX $1.04
  • Resistance Level
  • ENVB $6.10
  • SMX $1.78
  • Average True Range (ATR)
  • ENVB 0.90
  • SMX 0.44
  • MACD
  • ENVB -0.19
  • SMX 0.11
  • Stochastic Oscillator
  • ENVB 20.64
  • SMX 65.46

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

Share on Social Networks: